At the heart of any biotechnology company is its intellectual property. The very first products of a biotech company are often the patents surrounding a core technology. The acquisition of patent rights is therefore of paramount importance to the ultimate success of the company.
Although many business professionals are aware of the general issues associated with acquiring patents, special problems exist with respect to prosecuting patent applications in the life sciences. In addition, the unique composition of many biotech startups requires special attention to certain recurring issues.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]